Clinical trial
The Pharmacogenetic Study, Readiness to Change, and Pharmacological…
NCT00495352 · Yu-Li Hospital, Other · Completed
Key facts
| NCT number | NCT00495352 |
|---|---|
| Title | The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia |
| Official title | 1. The Pharmacogenetic Study of Interaction Among Antipsychotics, Readiness to Change, and Pharmacological Intervention for Smoking Cessation Among Schizophrenic Patients 2. Stages of Change and Outcomes of Nicotine Replacement Therapy in Chronic Schizophrenic Patients |
| Acronym | PSIAARP |
| Lead sponsor | Yu-Li Hospital, Other |
| Collaborators | National Health Research Institutes, Taiwan Department of Health, Executive Yuan, R.O.C. (Taiwan) |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tobacco Dependence, Schizophrenia |
| Intervention type | Drug |
| Interventions | Hihg-doseNRT, Low-dose NRT, bupropion |
| Enrollment | 360 |
| Start date | Jan 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Jul 3, 2007 |
| Last update posted | Apr 14, 2010 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: